Alloy Therapeutics Stock

www.alloytx.comHealthcare / BioTech & PharmaFounded: 2020Funding to Date: $136.24MM

Alloy Therapeutics is a biotech ecosystem company, facilitating affordable, non-exclusive access to the entire drug discovery community from academic scientists, small and medium biotech, to the largest biopharma. The company's platform is a human therapeutic antibody discovery platform consisting of a growing suite of proprietary transgenic mice strains.

Register To Buy and Sell Shares

For more details on financing and valuation for Alloy Therapeutics, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

OverviewFinancingsValuation

Enterprise Value

Powered by Forge Data

Access Alloy Therapeutics’ valuation and stock price.

View secondary pricing information, VWAP and distribution waterfall. And seek potentially outsized returns with same day private market data for private companies like Alloy Therapeutics.

Become part of the Secondary Marketplace, catering to both individual and institutional investors.

Register

Animation displayed is not current and securities are shown for illustrative purposes only.

Team

Management Team

Errik Anderson
Founder & Chief Executive Officer
Heather Schwoebel
Chief Business Officer & Chief Operating Officer
Piotr Bobrowicz
Chief Scientific Officer
Logan Snyder
General Counsel
Ron Adner
Chief Strategy Officer
Dongxing Zha
Chief Technology Officer, TCR Discovery and Engineering
Rachel Rennard
Chief Technology Officer, Antibodies

Board Members

Jason Camm
Thiel Capital
Jason Coloma
Maze Therapeutics
Fabian Hansen
Presight Capital
Alex Kolicich
8VC
Ulrik B. Nielsen
Tidal Therapeutics
Logan Snyder
Ulysses Holdings
Anthony Sun
Zentera Therapeutics
Piotr bobrowwicz
Board Member
Alaa Halawa
Board Member

Frequently Asked Questions About Alloy Therapeutics’ Stock

plusminus
Can you buy Alloy Therapeutics’ stock?
Alloy Therapeutics is not publicly traded on NYSE or NASDAQ in the U.S. To buy Alloy Therapeutics’ stock you need to be an accredited investor. Learn more about how to invest in the private market or register today to get started.
plusminus
Can you sell Alloy Therapeutics’ stock?
Yes, you can sell stock of a private company like Alloy Therapeutics. Forge can help you sell your Alloy Therapeutics stock in a way that works for you and the company. So if you are seeking liquidity, register with us today to get started.
plusminus
What is Alloy Therapeutics’ stock price?
Alloy Therapeutics is a privately held company and therefore does not have a public stock price. However, you may access Alloy Therapeutics’ private market stock price with Forge Data.
plusminus
What is Alloy Therapeutics’ stock ticker symbol?
Alloy Therapeutics does not have an official ticker symbol because this company is not currently publicly traded.
plusminus
Can institutional investors buy and sell private market stocks?
Yes. As one of the largest trading platform for the private market, Forge helps institutional investors seek liquidity as they buy and sell private stock for their portfolios or their clients. Our private market specialists have decades of experience working with institutional firms. Learn more or register today to get started.

News Highlights

Alloy Therapeutics Raises $42M in Series D Financing
Alloy Therapeutics, a Boston, MA-based biotechnology ecosystem company, raised $42M in Series D funding
Updated on: Apr 20, 2024

PLEASE READ THESE IMPORTANT LEGAL NOTICES & DISCLOSURES

Public news articles listed on this page have been curated by Forge based on several factors including, but not limited to, product updates, changes in organization structure, funding rounds, third-party valuations, and key personnel changes. Changes to this list of articles can be made at any time without notice and should not be relied upon for investment purposes. Forge does not verify the accuracy of the information contained in public news articles.